Iran, September 2014, cancer medicines
|
Originator brand medicines surveyed Iran, September 2014, cancer medicines |
|
||||||
| Medicine name | Strength | Dosage form | Medicine list | EML | Originator brand name | Originator brand manufacturer | International reference price source MSH2013 (US $) |
| Capecitabine | 150 mg | cap/tab | Supplementary | Yes | Xeloda | Roche | 0.8498 |
| Cisplatin | 50 mg | injection | Supplementary | Yes | 10.6338 | ||
| Docetaxel | 80 mg | injection | Supplementary | Yes | Taxotere | Sanofi | 72.5939 |
| Imatinib | 400 mg | cap/tab | Supplementary | Yes | Glivec | Novartis | 4.2931 |
| Letrozole | 2.5 mg | cap/tab | Supplementary | Yes | Femara | Novartis | 0.7329 |
| Vincristine | 1 mg | injection | Supplementary | Yes | Oncovin | Eli Lilly | 11.1018 |